Emerging infectious diseases · 2020 · 26 citations · 41 references
MedicineHematologyInfectious DiseasesHemostasisImmunopathologyInflammationCoagulation AbnormalitiesCoagulation DisordersPlatelet AggregationPlatelet FunctionPlatelet PhysiologyThrombosisEndothelial Protein C PathwayIntercellular Adhesion Molecule 1Platelet Aggregation DefectsPlatelet-endothelial InteractionsProtein C Pathway ImpairmentTissue Factor ActivationVascular Cell Adhesion Molecule 1Von Willebrand Factor Function
Lassa fever (LF) causes multisystem disease and has a fatality rate <70%. Severe cases exhibit abnormal coagulation, endothelial barrier disruption, and dysfunctional platelet aggregation but the underlying mechanisms remain poorly understood. In Sierra Leone during 2015-2018, we assessed LF patients' day-of-admission plasma samples for levels of proteins necessary for coagulation, fibrinolysis, and platelet function. P-selectin, soluble endothelial protein C receptor, soluble thrombomodulin, plasminogen activator inhibitor 1, ADAMTS-13, von Willebrand factor, tissue factor, soluble intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 were more elevated in LF patients than in controls. Endothelial protein C receptor, thrombomodulin, intercellular adhesion molecule 1, plasminogen activator inhibitor 1, D-dimer, and hepatocyte growth factor were higher in fatal than nonfatal LF cases. Platelet disaggregation occurred only in samples from fatal LF cases. The impaired homeostasis and platelet dysfunction implicate alterations in the protein C pathway, which might contribute to the loss of endothelial barrier function in fatal infections.
41
Hematological Problems in Pediatric Intensive Care
Shoshana Revel‐Vilk, Peter N. Cox, Nancy Robitaille et al. · Pediatric and adolescent medicine · 2013 · 3.5K citations
Drotrecogin Alfa (Activated) in Adults with Septic Shock
V. Marco Ranieri, Bruce Thompson, Philip S. Barie et al. · New England Journal of Medicine · 2012 · 1.3K citations · Full text